Presentation description
Immunoglobulin G (IgG)-cleaving enzymes, IdeS and its homolog IdeZ, are being investigated as therapeutic tools to cleave and transiently reduce circulating IgG antibodies. Both enzymes specifically cleave IgG at the lower hinge region, generating F(ab')2 (divalent antigen-binding fragment) and Fc (fragment crystallizable) fragments, thereby disrupting Fc-mediated effector functions. Accurate evaluation of IgG cleavage requires quantitative methods for detecting intact IgG and cleavage fragments under biologically relevant conditions. The objective of this study was to develop and optimize a quantitative fluorescence-based Western blot assay for evaluating IgG cleavage by IdeS and IdeZ. Fluorescence-based Western blotting was optimized to quantitatively detect human IgG using fluorophore-conjugated antibodies targeting Fc, Fab, or heavy- and light-chain epitopes. Native and reducing electrophoretic conditions were performed in parallel to resolve intact IgG and enzymatic cleavage products. Assay sensitivity was assessed to establish practical quantitative ranges. The optimized assay was subsequently used to compare IgG cleavage by IdeS and IdeZ by quantitatively measuring residual intact IgG and the generation of cleavage fragments. Both enzymes efficiently cleaved human IgG while exhibiting differences in cleavage efficiency and fragment profiles, demonstrating the assay's ability to distinguish cleavage activity between enzymes. To support future cell-based studies, the detection method was evaluated in complete cell culture medium supplemented with fetal bovine serum. Despite the substantial protein background, fluorescence-based Western blotting reliably detected human IgG and its cleavage products, supporting its suitability for monitoring IgG cleavage in serum-containing media. Overall, this work establishes a versatile and highly sensitive fluorescence-based Western blotting method for quantitatively evaluating IgG-cleaving enzyme activity and provides a foundation for future mechanistic and cell-based studies of IgG-cleaving enzymes.
Presenter Name: Max Sumicad
Presentation Type: Poster
Presentation Format: In Person
Presentation #8
College: Pharmacy
School / Department: Molecular Pharmaceutics
Research Mentor: Kuo-Ching (KC) Mei
Additional Mentor: Zitao Ma
Time: 8:30 AM
Physical Location or Zoom link:
Dumke